Page last updated: 2024-08-24

3-iodobenzylguanidine and Infection

3-iodobenzylguanidine has been researched along with Infection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Diociaiuti, L; Mastrangelo, S; Riccardi, R; Rufini, V; Tornesello, A; Troncone, L	1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Infection

Article	Year
Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1 Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease Progression; Hematologic Diseases; Hemorrhage; Humans; Infant; Infections; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Prognosis; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction	1995

Article

Year

Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1

Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease Progression; Hematologic Diseases; Hemorrhage; Humans; Infant; Infections; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Prognosis; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction

1995